Intra-arterial therapies for colorectal cancer liver metastases (radioembolization excluded)

被引：13
作者：
de Baere, Thierry [1 ,2 ]
Tselikas, Lambros [1 ,2 ]
Boige, Valerie [1 ,2 ]
Ducreux, Michel [1 ,2 ]
Malka, David [1 ,2 ]
Goere, Diane [1 ,2 ]
Benahim, Eleonore [1 ,2 ]
Deschamps, Frederic [1 ,2 ]
机构：
[1] Gustave Roussy Canc Ctr, Dept Intervent Radiol, 114 Rue Edouard Vaillant, F-94805 Villejuif, France
[2] Univ Paris Sud XI, UFR Med, F-94270 Le Kremlin Bicetre, France
来源：
BULLETIN DU CANCER | 2017年 / 104卷 / 05期
关键词：
Colorectal cancer; Liver metastases; Local treatment; Hepatic arterial infusion chemotherapy; Transarterial chemoembolization; HEPATIC-ARTERIAL-INFUSION; IRINOTECAN-ELUTING BEADS; SYSTEMIC CHEMOTHERAPY; PORT CATHETER; PHASE-II; CHEMOEMBOLIZATION; OXALIPLATIN; PLACEMENT; RESECTION; SURVIVAL;
D O I：
10.1016/j.bulcan.2016.10.025
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
During the past 20 years, advances in systemic therapies have improved overall survival of patients with Colorectal cancer Liver metastases (CRLM) from 6 to 24 months. By reaching CRLM via their preferential arterial vascularization, hepatic arterial infusion of chemotherapy (HAIC) has demonstrated improvement in response rate and deepness of response. Improvement in deepness of response is potentially helpful to convert no surgical patient to surgery. Recent HAIC regimens, including HAIC-FUDR plus systemic oxaliplatin/irinotecan, or HAIC-oxaliplatin plus systemic 5FU and cetuximab yielded a 92% and 90% response rate respectively, and conversion to R0 surgery in 47% and 42% of patients, respectively. When HAIC delivered a drug ineffective through intravenous delivery, this rechallenge provided 62% response rate for HAIC. Nowadays, port-catheter implanted percutaneously by radiologists has 95% feasibility with primary patency equivalent to that of surgically implanted catheters, and secondary patency superior after radiologic revision. Retrospective studies demonstrated prolonged DFS of HAIC over IV chemotherapy in the adjuvant setting after surgery of CRLM. Drug eluting beads loaded with irinotecan (DEBIRI) were developed as drug carrier and embolization platform for treatment of CRLM by chemoembolization. DEBIRI allows for a very high level of SN-38 (SN-38 is the active compound of irinotecan) and a very high rate of complete l response at pathologic studies of treated metastases. DEBIRI was compared to systemic FOLFIRI in a phase III randomized trial including 74 patients with benefit in overall survival and disease-free survival.
引用
收藏
页码：402 / 406
页数：5
相关论文
共 34 条
[1]   Comparison of Complete Pathologic Response and Hepatic Injuries Between Hepatic Arterial Infusion and Systemic Administration of Oxaliplatin in Patients with Colorectal Liver Metastases [J].
Allard, Marc Antoine ;
Sebagh, Mylene ;
Baillie, Gaelle ;
Lemoine, Antoinette ;
Dartigues, Peggy ;
Faitot, Francois ;
Faron, Matthieu ;
Boige, Valerie ;
Vitadello, Fabrizio ;
Vibert, Eric ;
Elias, Dominique ;
Adam, Rene ;
Goere, Diane ;
Cunha, Antonio Sa .
ANNALS OF SURGICAL ONCOLOGY, 2015, 22 (06) :1925-1932
[2]   QUALITY-OF-LIFE AND SURVIVAL WITH CONTINUOUS HEPATIC-ARTERY FLOXURIDINE INFUSION FOR COLORECTAL LIVER METASTASES [J].
ALLENMERSH, TG ;
EARLAM, S ;
FORDY, C ;
ABRAMS, K ;
HOUGHTON, J .
LANCET, 1994, 344 (8932) :1255-1260
[3]   Regional Hepatic Chemotherapies in Treatment of Colorectal Cancer Metastases to the Liver [J].
Ammon, John B. ;
Kemeny, Nancy E. .
SEMINARS IN ONCOLOGY, 2010, 37 (02) :139-148
[4]   Placement of an arterial hepatic catheter after a major hepatectomy for colorectal liver metastases: Is this safe? [J].
Benhaim, L. ;
Goere, D. ;
Deschamps, F. ;
Dumont, F. ;
Bonnet, S. ;
Honore, C. ;
Malka, D. ;
Boige, V. ;
De Baere, T. ;
Elias, D. .
EJSO, 2013, 39 (06) :640-647
[5]   Hepatic arterial infusion of oxaliplatin and intravenous LV5FU2 in unresectable liver metastases from colorectal cancer after systemic chemotherapy failure [J].
Boige, Valerie ;
Malka, David ;
Elias, Dominique ;
Castaing, Marine ;
De Baere, Thierry ;
Goere, Diane ;
Dromain, Clarisse ;
Pocard, Marc ;
Ducreux, Michel .
ANNALS OF SURGICAL ONCOLOGY, 2008, 15 (01) :219-226
[6]   Mechanisms of vascularization in murine models of primary and metastatic tumor growth [J].
Bugyik, Edina ;
Renyi-Vamos, Ferenc ;
Szabo, Vanessza ;
Dezso, Katalin ;
Ecker, Nora ;
Rokusz, Andras ;
Nagy, Peter ;
Dome, Balazs ;
Paku, Sandor .
CHINESE JOURNAL OF CANCER, 2016, 35
[7]   Intra-Arterial Hepatic Chemotherapy: A Comparison of Percutaneous Versus Surgical Implantation of Port-Catheters [J].
Deschamps, F. ;
Elias, D. ;
Goere, D. ;
Malka, D. ;
Ducreux, M. ;
Boige, V. ;
Auperin, A. ;
de Baere, T. .
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2011, 34 (05) :973-979
[8]   Percutaneous Femoral Implantation of an Arterial Port Catheter for Intraarterial Chemotherapy: Feasibility and Predictive Factors of Long-term Functionality [J].
Deschamps, Frederic ;
Rao, Pramod ;
Teriitehau, Christophe ;
Hakime, Antoine ;
Malka, David ;
Boige, Valerie ;
Ducreux, Michel ;
Elias, Dominique ;
Goere, Diane ;
de Baere, Thierry .
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2010, 21 (11) :1681-1688
[9]   Interventional revisions of malfunctions affecting surgically implanted port-catheters for hepatic artery infusion [J].
Farouil, Geoffroy ;
Deschamps, Frederic ;
Barah, Alireza ;
Auperin, Anne ;
Goere, Diane ;
Elias, Dominique ;
de Baere, Thierry .
SURGICAL ONCOLOGY-OXFORD, 2013, 22 (01) :48-54
[10]  
Fiorentini G, 2012, ANTICANCER RES, V32, P1387
1234